Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H15N2O2 |
Molecular Weight | 147.1955 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
C[N+](C)(C)CCOC(N)=O
InChI
InChIKey=VPJXQGSRWJZDOB-UHFFFAOYSA-O
InChI=1S/C6H14N2O2/c1-8(2,3)4-5-10-6(7)9/h4-5H2,1-3H3,(H-,7,9)/p+1
Molecular Formula | C6H15N2O2 |
Molecular Weight | 147.1955 |
Charge | 1 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | NONE |
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 |
6.0 mM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | MIOSTAT Approved UseIntraocular use for obtaining miosis during surgery. In addition, MIOSTAT (carbachol intraocular solution, USP) reduces the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery. Launch Date1972 |
PubMed
Title | Date | PubMed |
---|---|---|
Avoidance learning: long-lasting deficits after temporal lobe seizure. | 1969 Dec 12 |
|
[Tremor following intracerebral carbachol injection. 1.Carbachol sensitivity of various brain structures]. | 1975 |
|
Spasmolytic constituents of Cedrus deodara (Roxb.) Loud: pharmacological evaluation of himachalol. | 1975 Feb |
|
A crucial epileptogenic site in the deep prepiriform cortex. | 1985 Oct 17-23 |
|
Novel 'soft' anticholinergic agents. | 1988 Feb |
|
Chick optic lobe contains a developmentally regulated alpha2alpha5beta2 nicotinic receptor subtype. | 2000 Aug |
|
Cardiovascular studies on different classes of soft drugs. | 2000 Mar |
|
PLD pathway involved in carbachol-induced Cl- secretion: possible role of TNF-alpha. | 2001 Apr |
|
Low-affinity M(2) receptor binding state mediates mouse atrial bradycardia: comparative effects of carbamylcholine and the M(1) receptor agonists sabcomeline and xanomeline. | 2001 Mar |
|
Regional differences in functional receptor distribution and calcium mobilization in the intact human lens. | 2001 Sep |
|
The role of endogenous human Trp4 in regulating carbachol-induced calcium oscillations in HEK-293 cells. | 2002 Apr 19 |
|
The relationship between hippocampal acetylcholine release and cholinergic convulsant sensitivity in withdrawal seizure-prone and withdrawal seizure-resistant selected mouse lines. | 2002 Aug |
|
Regeneration of cardiomyocytes from bone marrow: Use of mesenchymal stem cell for cardiovascular tissue engineering. | 2003 Mar |
|
Post-seizures amygdaloallocortical microvascular lesion leading to atrophy and memory impairment. | 2005 Aug |
|
Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics. | 2005 Dec |
|
Theoretical and experimental investigation of calcium-contraction coupling in airway smooth muscle. | 2006 |
|
Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells. | 2006 Jul |
|
Gene transfer of neuronal nitric oxide synthase into intracardiac Ganglia reverses vagal impairment in hypertensive rats. | 2007 Feb |
|
Endogenous RGS proteins modulate SA and AV nodal functions in isolated heart: implications for sick sinus syndrome and AV block. | 2007 May |
|
Structural and functional effects of developmental exposure to ethanol on the zebrafish heart. | 2010 Jun |
Patents
Sample Use Guides
MIOSTAT (CARBACHOL INTRAOCULAR SOLUTION, USP) 0.01%
Aseptically remove the sterile vial from the blister package by peeling the backing paper and dropping the vial onto a sterile tray. Withdraw the contents into a dry sterile syringe, and replace the needle with an atraumatic cannula prior to intraocular instillation. No more than one-half milliliter should be gently instilled into the anterior chamber for the production of satisfactory miosis. It may be instilled before or after securing sutures. Miosis is usually maximal within two to five minutes after application.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27118568
In the dose-course studies, carbachol showed significant increase in phosphorylation of MYPT1 at Thr696 (p-MYPT1) from concentrations of 15-100 μM based on Western blot results (p < 0.05, ANOVA test). In the time-course studies, treatment of cells with 15 μM of carbachol significantly enhanced the expression of p-MYPT1 from 3 to 15 h (p < 0.05, ANOVA test) and induced the expression of Rho A from 10 to 120 min (p < 0.05, ANOVA test).
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:59:37 GMT 2025
by
admin
on
Mon Mar 31 17:59:37 GMT 2025
|
Record UNII |
54Z8M50D6Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175884
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
||
|
NDF-RT |
N0000175369
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0048397
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | |||
|
DB00411
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | |||
|
2551
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | |||
|
54Z8M50D6Q
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | |||
|
1546387
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | RxNorm | ||
|
462-58-8
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY | |||
|
54Z8M50D6Q
Created by
admin on Mon Mar 31 17:59:37 GMT 2025 , Edited by admin on Mon Mar 31 17:59:37 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |